cholestyramine resin has been researched along with quinidine in 7 studies
| Studies (cholestyramine resin) | Trials (cholestyramine resin) | Recent Studies (post-2010) (cholestyramine resin) | Studies (quinidine) | Trials (quinidine) | Recent Studies (post-2010) (quinidine) |
|---|---|---|---|---|---|
| 2,669 | 342 | 190 | 6,608 | 387 | 594 |
| Protein | Taxonomy | cholestyramine resin (IC50) | quinidine (IC50) |
|---|---|---|---|
| Voltage-dependent L-type calcium channel subunit alpha-1F | Homo sapiens (human) | 6.4 | |
| Cholinesterase | Homo sapiens (human) | 1.23 | |
| ATP-dependent translocase ABCB1 | Mus musculus (house mouse) | 10 | |
| ATP-dependent translocase ABCB1 | Homo sapiens (human) | 3.32 | |
| Cytochrome P450 2D26 | Rattus norvegicus (Norway rat) | 2.8 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 0.3532 | |
| Potassium voltage-gated channel subfamily A member 5 | Homo sapiens (human) | 7.3 | |
| Cholinesterase | Equus caballus (horse) | 7.37 | |
| Voltage-dependent L-type calcium channel subunit alpha-1D | Homo sapiens (human) | 6.4 | |
| Potassium voltage-gated channel subfamily H member 2 | Homo sapiens (human) | 0.7882 | |
| Voltage-dependent L-type calcium channel subunit alpha-1S | Homo sapiens (human) | 6.4 | |
| Voltage-dependent L-type calcium channel subunit alpha-1C | Homo sapiens (human) | 6.4 | |
| Sodium channel protein type 5 subunit alpha | Homo sapiens (human) | 6.9 | |
| Potassium voltage-gated channel subfamily D member 2 | Rattus norvegicus (Norway rat) | 2.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (71.43) | 18.7374 |
| 1990's | 2 (28.57) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Sellers, E; Weser, JK | 1 |
| Haber, E; Smith, TW | 1 |
| Bailey, KR; Gallo, DG; Sheffner, AL | 1 |
| Risler, T; Seipel, L | 1 |
| Wirth, KE | 1 |
| RuDusky, BM | 2 |
3 review(s) available for cholestyramine resin and quinidine
| Article | Year |
|---|---|
Drug interactions with coumarin anticoagulants. 2.
Topics: Allopurinol; Anabolic Agents; Animals; Anti-Bacterial Agents; Anticoagulants; Barbiturates; Chloral Hydrate; Chloramphenicol; Cholestyramine Resin; Clofibrate; Contraceptives, Oral; Coumarins; Dextrothyroxine; Diuretics; Drug Antagonism; Drug Synergism; Ethacrynic Acid; Ethanol; Glucagon; Glucocorticoids; Glutethimide; Humans; Oxyphenbutazone; Phenylbutazone; Quinidine; Quinine; Quinolines; Salicylates; Sulfinpyrazone; Sulfonamides; Thyroid Hormones; Tolbutamide | 1971 |
Digitalis (fourth of four parts).
Topics: Animals; Antibodies; Arrhythmias, Cardiac; Cardiac Glycosides; Cholestyramine Resin; Digitalis; Digitalis Glycosides; Dogs; Electric Countershock; Half-Life; Heart Conduction System; Heart Rate; Humans; Immunoglobulin Fab Fragments; Lidocaine; Neurologic Manifestations; Phenytoin; Plants, Medicinal; Plants, Toxic; Potassium; Procainamide; Propranolol; Quinidine | 1973 |
[Drug interactions in the use of cardiac glycosides].
Topics: Blood Proteins; Cardiac Glycosides; Charcoal; Cholestyramine Resin; Colestipol; Drug Interactions; Humans; Intestinal Absorption; Magnesium; Protein Binding; Quinidine; Receptors, Drug; Thyroid Hormones; Tissue Distribution | 1981 |
4 other study(ies) available for cholestyramine resin and quinidine
| Article | Year |
|---|---|
The interaction between cholestyramine and drugs.
Topics: Adsorption; Animals; Aspirin; Bile Acids and Salts; Blood; Chlorothiazide; Cholestyramine Resin; Dogs; Intestinal Absorption; Nicotinic Acids; Phenobarbital; Phenylbutazone; Quinidine; Rats; Spectrophotometry; Tetracycline; Urine; Warfarin | 1965 |
[Controlled digitalis therapy].
Topics: Cholestyramine Resin; Digitalis Glycosides; Digitoxin; Digoxin; Dose-Response Relationship, Drug; Drug Interactions; Heart Failure; Humans; Patient Compliance; Phenobarbital; Quinidine; Rifampin | 1983 |
Cholestyramine therapy for quinidine-induced diarrhea. Case reports.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Antidiarrheals; Cholestyramine Resin; Diarrhea; Female; Humans; Male; Middle Aged; Quinidine | 1997 |
Treatment of quinidine-induced diarrhea: implications for enhanced control of atrial fibrillation in the geriatric population.
Topics: Aged; Aged, 80 and over; Anti-Arrhythmia Agents; Antidiarrheals; Atrial Fibrillation; Cholestyramine Resin; Diarrhea; Humans; Quinidine | 1998 |